Laura A. Lane
Corporate Officer/Principal chez ELI LILLY AND COMPANY
Postes actifs de Laura A. Lane
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/08/2022 | - |
Historique de carrière de Laura A. Lane
Anciens postes connus de Laura A. Lane
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Analyste en capital-investissement | 01/03/2019 | 01/10/2021 |
| Private Equity Investor | 01/10/2021 | 01/08/2022 | |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Directeur des opérations | 01/03/2015 | 30/06/2018 |
| Fondateur | 01/03/2015 | 30/06/2018 |
Formation de Laura A. Lane
| University of Cambridge | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Private Equity Analyst | 1 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Laura A. Lane
- Expérience
